Literature DB >> 23341442

Elevated nuclear factor erythroid-2 levels promote epo-independent erythroid maturation and recapitulate the hematopoietic stem cell and common myeloid progenitor expansion observed in polycythemia vera patients.

Ruzhica Bogeska1, Heike L Pahl.   

Abstract

The molecular etiology of polycythemia vera (PV) remains incompletely understood. Patients harbor increased numbers of hematopoietic stem cells and display Epo-independent erythroid maturation. However, the molecular mechanism underlying Epo hypersensitivity and stem cell expansion is unclear. We have previously shown that the transcription factor nuclear factor erythroid-2 (NF-E2) is overexpressed in the majority of PV patients. Here we demonstrated that elevation of NF-E2 expression in healthy CD34(+) cells to levels observed in PV caused Epo-independent erythroid maturation and expansion of hematopoietic stem cell (HSC) and common myeloid progenitor (CMP) cell numbers. Silencing NF-E2 in PV patients reverted both aberrancies, demonstrating for the first time that NF-E2 overexpression is both required and sufficient for Epo independence and HSC/CMP expansion in PV.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23341442      PMCID: PMC3659758          DOI: 10.5966/sctm.2012-0046

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  24 in total

1.  Gene expression profiling in polycythaemia vera: overexpression of transcription factor NF-E2.

Authors:  Philipp S Goerttler; Clemens Kreutz; Johannes Donauer; Daniel Faller; Thomas Maiwald; Edith März; Brigitta Rumberger; Titus Sparna; Annette Schmitt-Gräff; Jochen Wilpert; Jens Timmer; Gerd Walz; Heike L Pahl
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

2.  The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera.

Authors:  Holger Cario; Philipp S Goerttler; Cordula Steimle; Ross L Levine; Heike L Pahl
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

3.  Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2(V617F) in granulocytes.

Authors:  Terra L Lasho; Ruben Mesa; D Gary Gilliland; Ayalew Tefferi
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

4.  Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia.

Authors:  Sonny O Ang; Hua Chen; Kiichi Hirota; Victor R Gordeuk; Jaroslav Jelinek; Yongli Guan; Enli Liu; Adelina I Sergueeva; Galina Y Miasnikova; David Mole; Patrick H Maxwell; David W Stockton; Gregg L Semenza; Josef T Prchal
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

5.  Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.

Authors:  R Kralovics; K Indrak; T Stopka; B W Berman; J F Prchal; J T Prchal
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

6.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

7.  Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells.

Authors:  Loïc Garçon; Catherine Lacout; Fédor Svinartchouk; Jean-Pierre Le Couédic; Jean-Luc Villeval; William Vainchenker; Dominique Duménil
Journal:  Blood       Date:  2004-10-26       Impact factor: 22.113

8.  Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.

Authors:  R Kralovics; L Sokol; J T Prchal
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

9.  Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.

Authors:  L Sokol; M Luhovy; Y Guan; J F Prchal; G L Semenza; J T Prchal
Journal:  Blood       Date:  1995-07-01       Impact factor: 22.113

10.  A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2.

Authors:  Kai B Kaufmann; Albert Gründer; Tobias Hadlich; Julius Wehrle; Monika Gothwal; Ruzhica Bogeska; Thalia S Seeger; Sarah Kayser; Kien-Binh Pham; Jonas S Jutzi; Lucas Ganzenmüller; Doris Steinemann; Brigitte Schlegelberger; Julia M Wagner; Manfred Jung; Britta Will; Ulrich Steidl; Konrad Aumann; Martin Werner; Thomas Günther; Roland Schüle; Alessandro Rambaldi; Heike L Pahl
Journal:  J Exp Med       Date:  2012-01-09       Impact factor: 14.307

View more
  4 in total

Review 1.  Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells.

Authors:  Jadwiga J Gasiorek; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2015-02-27       Impact factor: 9.261

Review 2.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

3.  RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling.

Authors:  Katarina Kapralova; Lucie Lanikova; Felipe Lorenzo; Jihyun Song; Monika Horvathova; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

Review 4.  The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.

Authors:  Mads Emil Bjørn; Hans Carl Hasselbalch
Journal:  Mediators Inflamm       Date:  2015-10-11       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.